7 Drug Stocks To Consider As Biosimilars Pick Up Pace
October 20, 2016 at 14:53 PM EDT
Interest in biosimilars has picked up considerably with Pfizer, Inc.’s announcement this week regarding its plans to launch a biosimilar version of Johnson & Johnson’s blockbuster drug, Remicade, in late November.